© 2022 Iowa Public Radio
IPR20012_Website_Header_Option2_NewsNavy.png
Play Live Radio
Next Up:
0:00
0:00
Available On Air Stations

Chikungunya, Mosquitoes, and a Vaccine

14950675740_191bd10378_b.jpg
Sanofi Pasteur / Patrick Boulen
/
Yellow Fever vaccine manufacturing facility Val de Reuil Sanofi Pasteur site, France, June 2013

Chikungunya is a debilitating inflammatory virus carried by mosquitoes. The University of Iowa is one of three sites in the U.S. that is enrolling participants for a clinical trial of an experimental vaccine for chikungunya. The illness has been found in the U.S. and in Iowa, but it is not currently a widespread concern across the country. 
 
Iowa's State Epidemiologist Patricia Quinlisk says that, "most of the people who going to be at risk are people  who travel particularly to tropical areas."
 
In this River to River segment, host Ben Kieffer is joined by Quinlisk, as well as University of Iowa professor of internal medicine, Patricia Winokur, who explains how the vaccine was developed and how the trials are conducted.
 
Also joining the conversation is assistant professor of entomology at Iowa State University, Ryan Smith. He studies mosquitoes and how they transmit disease. This summer he will continue work on trapping and testing mosquitoes in Iowa.

Ben Kieffer is the host of IPR's River to River